Literature DB >> 21506294

Chemotherapy-induced cardiomyopathy.

Syed Wamique Yusuf1, Nasreen A Ilias-Khan, Jean-Bernard Durand.   

Abstract

Improvement in cancer therapy has led to an increasing number of cancer survivors, some of whom may suffer from the cardiotoxic effects of chemotherapy. Cardiomyopathy can occur years after completion of the chemotherapy and it is important to recognize this early, as complete recovery of cardiac function is possible in some cases. In this article we will review chemotherapy-induced cardiomyopathy and discuss its treatment options.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506294     DOI: 10.1586/erc.10.188

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  2 in total

1.  Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity.

Authors:  Kisho Ohtani; Takeo Fujino; Tomomi Ide; Kouta Funakoshi; Ichirou Sakamoto; Ken-Ichi Hiasa; Taiki Higo; Kenjiro Kamezaki; Koichi Akashi; Hiroyuki Tsutsui
Journal:  Clin Res Cardiol       Date:  2018-10-26       Impact factor: 5.460

2.  Identifying temporal patterns in patient disease trajectories using dynamic time warping: A population-based study.

Authors:  Alexia Giannoula; Alba Gutierrez-Sacristán; Álex Bravo; Ferran Sanz; Laura I Furlong
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.